Question 1

What is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency is a very rare endocrine condition that affects adrenal steroid synthesis, leading to a combination of glucocorticoid deficiency, hypergonadotropic hypogonadism, and severe hypokalemic hypertension. The condition is caused by pathogenic variants in the CYP17A1 gene, which plays a critical role in the production of several steroid hormones. It typically presents in childhood or adolescence with hormonal imbalances affecting growth and sexual development. In terms of prevalence, this condition affects roughly 1 to 9 individuals per million, underscoring its rarity.

Question 2

What are the symptoms of congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

The clinical presentation is characterized primarily by severe high blood pressure due to an excess of mineralocorticoid precursors, alongside hormonal imbalances that result in glucocorticoid deficiency and sexual development abnormalities. Patients commonly exhibit features such as hypokalemia, abnormal responses to ACTH stimulation, elevated levels of certain adrenal hormones, and in many cases, primary amenorrhea in females or bilateral cryptorchidism in males. Additional hormonal findings include altered levels of gonadotropins and sex steroids, which contribute to the hypergonadotropic hypogonadism observed in this condition. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

This condition results from pathogenic variants in the CYP17A1 gene, which encodes an enzyme essential for the biosynthesis of steroid hormones. Disruption of this enzyme’s function impairs the production of glucocorticoids and sex steroids, while leading to an accumulation of mineralocorticoid precursors that contribute to hypertension. It is inherited in an autosomal recessive pattern, meaning that an individual must inherit two altered copies of the gene to be affected. This condition is more common when parents share a common ancestor, as both may be carriers of the rare variant; carrier testing may be particularly relevant for families with shared ancestry. Each child of two carrier parents has a 25% chance of being affected. Associated genes include CYP17A1.

Question 4

How is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency inherited?

Accepted Answer

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency is classified as rare. The estimated prevalence is approximately 1-9 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency diagnosed?

Accepted Answer

The gold standard for diagnosis is molecular genetic testing, which involves identifying pathogenic variants in the CYP17A1 gene. Clinical evaluation, including assessment of characteristic hormonal imbalances such as low cortisol levels, elevated ACTH, and abnormal responses to stimulation tests, further supports the diagnosis. Because many of these features can overlap with other conditions, definitive diagnosis relies on combining genetic testing with a thorough clinical evaluation.

Question 7

Are there treatments for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

Currently, management focuses on supportive care and symptom management, as no specific FDA-approved or foundational therapies are available for this condition. Treatment is tailored to the individual and typically involves a multidisciplinary team to address the various endocrine and cardiovascular issues that may arise. Long-term management includes regular surveillance to monitor blood pressure, electrolyte levels, and hormonal balance, ensuring that complications are identified early. Patients should discuss treatment options with their healthcare team to determine which therapies may be most appropriate, and genetic counseling is recommended to help families understand inheritance risks and family planning options.

Question 8

Are there clinical trials for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

Yes, there is currently 1 active clinical trial for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What complications can arise from congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

Complications from congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency can include severe high blood pressure and hormonal imbalances. These issues may lead to problems with growth and sexual development, as well as electrolyte imbalances like hypokalemia. Regular monitoring is important to catch any complications early.

Question 10

How does congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency affect daily life?

Accepted Answer

Living with congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency often requires careful management of blood pressure and hormone levels. Patients may need to take medications regularly and attend frequent check-ups with their healthcare team. Support from family and friends can also be very helpful in managing daily challenges.

Question 11

What is the long-term prognosis for someone with congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

The long-term prognosis for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency varies from person to person. Many individuals can manage their symptoms effectively and lead productive lives with proper care. However, ongoing follow-up with healthcare specialists is essential to ensure that any complications are addressed promptly.

Question 12

What should families consider regarding family planning with congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Accepted Answer

Families considering having children should be aware that congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency is inherited in an autosomal recessive pattern. This means both parents must be carriers for a child to be affected. Genetic counseling can provide valuable information about the risks and help families make informed decisions.

Organ System	Phenotype Count	Example Features
Hormones	10	Adrenal hyperplasia, Primary amenorrhea, Congenital adrenal hyperplasia
Lab test results	3	Decreased circulating cortisol level, Elevated circulating follicle stimulating hormone level, Elevated circulating luteinizing hormone level
Heart and blood vessels	1	Hypertension
Pregnancy and birth	1	Congenital adrenal hyperplasia
Kidneys and urinary system	1	Increased urinary 11-deoxycorticosterone level
Bones and joints	1	Delayed skeletal maturation
Growth and development	1	Failure to thrive
Muscles	1	Muscle spasm
Eyes	1	Blind vagina

Kisho

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency

Overview

Clinical Presentation

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

What are the symptoms of congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

What causes congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

How is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency inherited?

How rare is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

How is congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency diagnosed?

Are there treatments for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

Are there clinical trials for congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

What complications can arise from congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

How does congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency affect daily life?

What is the long-term prognosis for someone with congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?

What should families consider regarding family planning with congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency?